These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6909045)

  • 1. Estrogen receptors and advanced breast cancer.
    Reich SD
    Cancer Nurs; 1981 Jun; 4(3):247-8. PubMed ID: 6909045
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of tamoxifen in advanced male breast cancer.
    Patterson JS; Battersby LA; Bach BK
    Cancer Treat Rep; 1980; 64(6-7):801-4. PubMed ID: 7427964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer. The hormone factor.
    Wissing VS
    Am J Nurs; 1984 Sep; 84(9):1117-9. PubMed ID: 6566508
    [No Abstract]   [Full Text] [Related]  

  • 4. Tamoxifen for patients with estrogen receptor-negative breast cancer.
    Swain SM
    J Clin Oncol; 2001 Sep; 19(18 Suppl):93S-97S. PubMed ID: 11560981
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic effect of tamoxifen versus combined tamoxifen and diethylstilboestrol in advanced breast cancer in postmenopausal women.
    Mouridsen HT; Salimtschik M; Dombernowsky P; Gelshoj K; Palshof T; Rorth M; Daehnfeldt JL; Rose C
    Eur J Cancer (1965); 1980; Suppl 1():107-10. PubMed ID: 7032918
    [No Abstract]   [Full Text] [Related]  

  • 6. Progesterone receptor testing: not the right time to be buried.
    Colozza M; Larsimont D; Piccart MJ
    J Clin Oncol; 2005 Jun; 23(16):3867-8; author reply 3869-70. PubMed ID: 15923594
    [No Abstract]   [Full Text] [Related]  

  • 7. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB; Feuer EJ; Harlan LC; Abrams J
    J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability of immunocytochemical assay of estrogen receptors on breast cancer aspirates as a predictor of clinical response to hormone therapy.
    Ciatto S; Pacini P; Confortini M; Massimo V
    Acta Cytol; 1994; 38(4):666-7. PubMed ID: 8042436
    [No Abstract]   [Full Text] [Related]  

  • 9. Symposium on the management of early breast cancer (stages I and II). Part II: Clinical experience with treatment methods. 5. Adjuvant endocrine therapy.
    Palshof T
    Can J Surg; 1981 Jul; 24(4):379-84. PubMed ID: 7023634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of response to tamoxifen among Iraqi patients with advanced breast cancer.
    al-Alwan NA; al-Kubaisy W; al-Rawaq K
    East Mediterr Health J; 2000; 6(2-3):475-82. PubMed ID: 11556039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen therapy in premenopausal patients with metastatic breast cancer.
    Pritchard KI; Thomson DB; Myers RE; Sutherland DJ; Mobbs BG; Meakin JW
    Cancer Treat Rep; 1980; 64(6-7):787-96. PubMed ID: 7427962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen and progesterone receptors in the endometrium of postmenopausal breast cancer patients treated with tamoxifen and progestogens.
    Cohen I; Altaras MM; Beyth Y; Shapira J; Figer A; Tepper R; Cordoba M; Yigal D; Bernheim J
    Gynecol Oncol; 1997 Apr; 65(1):83-8. PubMed ID: 9103396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hormonreceptors in the therapy concept of breast cancer (author's transl)].
    Jonat W; Maass H
    Arch Geschwulstforsch; 1981; 51(7):637-41. PubMed ID: 7337546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen and oophorectomy in the treatment of recurrent breast cancer: a Southwest Oncology Group Study.
    Hoogstraten B; Fletcher WS; Gad-el-Mawla N; Maloney T; Altman SJ; Vaughn CB; Foulkes MA
    Cancer Res; 1982 Nov; 42(11):4788-91. PubMed ID: 7127314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the role of progesterone receptors in breast cancer.
    Fuqua SA; Cui Y; Lee AV; Osborne CK; Horwitz KB
    J Clin Oncol; 2005 Feb; 23(4):931-2; author reply 932-3. PubMed ID: 15681552
    [No Abstract]   [Full Text] [Related]  

  • 16. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M; Kodama T
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of advanced breast cancer.
    Baum M
    Br J Hosp Med; 1980 Jan; 23(1):32, 35, 37-9. PubMed ID: 6153539
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer.
    Foekens JA; Diamandis EP; Yu H; Look MP; Meijer-van Gelder ME; van Putten WL; Klijn JG
    Br J Cancer; 1999 Feb; 79(5-6):888-94. PubMed ID: 10070886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Fisher B; Costantino JP; Wickerham DL; Cecchini RS; Cronin WM; Robidoux A; Bevers TB; Kavanah MT; Atkins JN; Margolese RG; Runowicz CD; James JM; Ford LG; Wolmark N
    J Natl Cancer Inst; 2005 Nov; 97(22):1652-62. PubMed ID: 16288118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tamoxifen: modern drug therapy of estrogen-dependent breast tumors].
    Jovanović-Mićić D; Beleslin DB; Nikolić SS
    Med Pregl; 1996; 49(7-8):287-90. PubMed ID: 8926945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.